APA (7th ed.) Citation

KMM, V., KR, M., X, W., C, D., JPD, C., H, W., . . . JA, S. (2025). Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: A retrospective comparative cohort study. The Lancet. Rheumatology, 7(4), e226. https://doi.org/10.1016/S2665-9913(24)00402-8

Chicago Style (17th ed.) Citation

KMM, Vanni, et al. "Safety of CAR T-cell Therapy for Cancer in Pre-existing Autoimmune or Inflammatory Disease: A Retrospective Comparative Cohort Study." The Lancet. Rheumatology 7, no. 4 (2025): e226. https://doi.org/10.1016/S2665-9913(24)00402-8.

MLA (9th ed.) Citation

KMM, Vanni, et al. "Safety of CAR T-cell Therapy for Cancer in Pre-existing Autoimmune or Inflammatory Disease: A Retrospective Comparative Cohort Study." The Lancet. Rheumatology, vol. 7, no. 4, 2025, p. e226, https://doi.org/10.1016/S2665-9913(24)00402-8.